Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 114
Filtrar
1.
J Pediatr Gastroenterol Nutr ; 54(1): 136-60, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22197856

RESUMO

OBJECTIVE: Diagnostic criteria for coeliac disease (CD) from the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) were published in 1990. Since then, the autoantigen in CD, tissue transglutaminase, has been identified; the perception of CD has changed from that of a rather uncommon enteropathy to a common multiorgan disease strongly dependent on the haplotypes human leukocyte antigen (HLA)-DQ2 and HLA-DQ8; and CD-specific antibody tests have improved. METHODS: A panel of 17 experts defined CD and developed new diagnostic criteria based on the Delphi process. Two groups of patients were defined with different diagnostic approaches to diagnose CD: children with symptoms suggestive of CD (group 1) and asymptomatic children at increased risk for CD (group 2). The 2004 National Institutes of Health/Agency for Healthcare Research and Quality report and a systematic literature search on antibody tests for CD in paediatric patients covering the years 2004 to 2009 was the basis for the evidence-based recommendations on CD-specific antibody testing. RESULTS: In group 1, the diagnosis of CD is based on symptoms, positive serology, and histology that is consistent with CD. If immunoglobulin A anti-tissue transglutaminase type 2 antibody titers are high (>10 times the upper limit of normal), then the option is to diagnose CD without duodenal biopsies by applying a strict protocol with further laboratory tests. In group 2, the diagnosis of CD is based on positive serology and histology. HLA-DQ2 and HLA-DQ8 testing is valuable because CD is unlikely if both haplotypes are negative. CONCLUSIONS: The aim of the new guidelines was to achieve a high diagnostic accuracy and to reduce the burden for patients and their families. The performance of these guidelines in clinical practice should be evaluated prospectively.


Assuntos
Doença Celíaca/diagnóstico , Duodeno/patologia , Antígenos HLA-DQ/sangue , Imunoglobulina A/sangue , Transglutaminases/imunologia , Adolescente , Doença Celíaca/imunologia , Doença Celíaca/patologia , Criança , Humanos
2.
J Pediatr Gastroenterol Nutr ; 54(1): 15-9, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21716133

RESUMO

BACKGROUND AND OBJECTIVES: A revision of criteria for diagnosing coeliac disease (CD) is being conducted by The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). In parallel, we have performed a survey aimed to evaluate present practices for CD among paediatric gastroenterologists and to learn their views on the need for modification of present criteria for CD diagnosis. PATIENTS AND METHODS: Questionnaires were distributed to experienced paediatric gastroenterologists (ESPGHAN members) via the Internet. RESULTS: Overall, 95 valid questionnaires were available for analysis, pertaining to 28 different countries, with the majority of responders treating patients with CD for >15 years. Only about 12% of the responders comply with present criteria, noncompliance being related mainly to the challenge policy. Approximately 90% request a revision and modification of the present criteria. Forty-four percent want to omit the small bowel biopsy in symptomatic children with positive anti-tissue transglutaminase immunoglobulin (Ig) A or endomysial IgA antibodies, especially if they are DQ2/DQ8 positive. For silent cases detected by screening with convincingly positive anti-tissue transglutaminase IgA or EMA IgA, about 30% consider that no small bowel biopsy should be required in selected cases. Adding human leukocyte antigen typing in the diagnostic workup was asked for by 42% of the responders. As for gluten challenge, a new policy is advocated restricting its obligation to cases whenever the diagnosis is doubtful or unclear. CONCLUSIONS: Based on these opinions, revision of the ESPGHAN criteria for diagnosing CD is urgently needed.


Assuntos
Doença Celíaca/diagnóstico , Fidelidade a Diretrizes , Guias como Assunto , Padrões de Prática Médica , Adolescente , Adulto , Biópsia , Doença Celíaca/imunologia , Criança , Pré-Escolar , Glutens/imunologia , Pesquisas sobre Atenção à Saúde , Humanos , Imunoglobulina A/análise , Intestino Delgado , Sociedades Médicas , Inquéritos e Questionários , Transglutaminases/imunologia , Adulto Jovem
3.
Eur J Clin Nutr ; 65(6): 768-70, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21427748

RESUMO

An organized intervention program in pre-pubertal children based on increased physical education and activity together with nutritional advice to the children and their families may prevent obesity. Children aged 9 to 11 received double hours of weekly physical education lessons and additional nutritional advice for 2 years. They were compared with a similar group who received standard physical education lessons only. A total of 82 study and 26 control children completed the 2 years of the project. Boys in the control group gained significantly more weight than the corresponding study group (8.4 kg vs 3.2 kg, respectively (P<0.016)), control delta body mass index (BMI) 1.02 vs study 0.44 (P<0.012). There was no significant change in the weight or BMI in the girls. We conclude that the prevention of obesity may be attained by similar programs. Hormonal effects and compliance at this age may be responsible for the sex differences in this study.


Assuntos
Aconselhamento , Dieta , Exercício Físico , Obesidade/prevenção & controle , Educação Física e Treinamento , Instituições Acadêmicas , Índice de Massa Corporal , Estudos de Casos e Controles , Criança , Feminino , Humanos , Masculino , Fatores Sexuais , Aumento de Peso
4.
Acta Paediatr ; 99(1): 13-8, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19832739

RESUMO

BACKGROUND: Changes in the scope of the field of paediatrics and the variability in primary paediatric care (PPC) and practice throughout Europe motivated the European Paediatric Association and Union of National European Paediatric Societies and Associations (EPA/UNEPSA) to establish a working group to discuss definitions of paediatric coverage in terms of age limits, find common denominators in the provision of PPC and examine the challenges and goals of 21st century paediatrics relevant to the continent. These issues were presented at the 2008 Europaediatrics in Istanbul, where a consensus declaration was drawn up and accepted by the EPA/UNEPSA Executive Committee. AIM: To present an outline of the essential elements of the 2008 EPA/UNEPSA Executive Committee consensus declaration. CONCLUSION: The definition of basic characteristics and the establishment of requirements for optimal PPC and practice are important steps in overcoming the differences among European countries and pave the way for an acceptable formulation of standardized high-quality paediatric medical care in Europe.


Assuntos
Pediatria/normas , Atenção Primária à Saúde/normas , Adolescente , Criança , Continuidade da Assistência ao Paciente , Europa (Continente) , Humanos , Lactente , Programas Nacionais de Saúde/organização & administração , Pediatria/educação , Pediatria/tendências , Papel do Médico , Atenção Primária à Saúde/tendências , Adulto Jovem
6.
Arch Dis Child Fetal Neonatal Ed ; 88(5): F371-4, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12937039

RESUMO

OBJECTIVES: To define the incidence of congenital cytomegalovirus (CMV) infection in a defined population in Israel as diagnosed by urine polymerase chain reaction (PCR), and to assess the utility of this method for screening for congenital CMV infection. DESIGN: A convenient sample of urine specimens from asymptomatic newborns were subjected to CMV PCR. Positive results were validated by urine tube culture and by determination of serum CMV IgM antibodies. Maternal CMV IgG was determined in a representative sample of mothers. Newborns with positive urine specimens underwent full clinical evaluation. Epidemiological characteristics of the mothers were extracted from the medical records. SETTINGS: Two medical centres in Israel with different population characteristics. PATIENTS: A total of 2000 newborns (1000 in each medical centre). MAIN OUTCOME MEASURE: Presence of CMV DNA in the urine. RESULTS: Despite significant epidemiological differences between the populations in the two hospitals, the CMV seroprevalence was similar, 80.5% and 85%. Fourteen of the 2000 newborns screened (0.7%) were PCR positive. Urine culture was positive in nine of 10 specimens; IgM was positive in only two of 13 newborns with positive PCR. Eleven newborns underwent full or partial evaluation, and only one (9%) was symptomatic. CONCLUSIONS: The incidence of congenital CMV infection in the study population was 0.7%; over 90% were asymptomatic. Urinary CMV PCR is a reliable, rapid, and convenient method, and thus may serve as a screening tool for the detection of congenital CMV infection.


Assuntos
Infecções por Citomegalovirus/congênito , Reação em Cadeia da Polimerase/normas , Citomegalovirus/genética , Citomegalovirus/isolamento & purificação , Infecções por Citomegalovirus/diagnóstico , Infecções por Citomegalovirus/epidemiologia , DNA Viral/urina , Feminino , Sangue Fetal/virologia , Humanos , Imunoglobulina G/análise , Incidência , Recém-Nascido , Israel/epidemiologia , Masculino , Programas de Rastreamento/métodos , Programas de Rastreamento/normas , Reação em Cadeia da Polimerase/métodos , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/epidemiologia , Saúde da População Rural , Sensibilidade e Especificidade , Saúde da População Urbana
7.
Cancer ; 92(3): 684-90, 2001 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-11505416

RESUMO

BACKGROUND: Stomatitis is a common consequence of chemotherapy and a condition for which there is little effective treatment. Although the management of patients with other chemotherapy-related toxicities has improved in recent years, the incidence of stomatitis is increasing because of more intensive treatment and is often a dose limiting factor in chemotherapy. The authors assessed the efficacy of a homeopathic remedy, TRAUMEEL S(R), in the management of chemotherapy-induced stomatitis in children undergoing bone marrow transplantation. METHODS: A randomized, placebo-controlled, double-blind clinical trial was conducted in 32 patients ages 3-25 years who had undergone allogeneic (16 patients) or autologous (16 patients) stem cell transplantation. Of the 30 evaluable patients, 15 were assigned placebo, and 15 were assigned TRAUMEEL S both as a mouth rinse, administered five times daily from 2 days after transplantation for a minimum of 14 days, or until at least 2 days after all signs of stomatitis were absent. Stomatitis scores were evaluated according to the World Health Organization grading system for mucositis. RESULTS: A total of five patients (33%) in the TRAUMEEL S treatment group did not develop stomatitis compared with only one patient (7%) in the placebo group. Stomatitis worsened in only 7 patients (47%) in the TRAUMEEL S treatment group compared with 14 patients (93%) in the placebo group. The mean area under the curve stomatitis scores were 10.4 in the TRAUMEEL S treatment group and 24.3 in the placebo group. This difference was statistically significant (P < 0.01). CONCLUSIONS: This study indicates that TRAUMEEL S may reduce significantly the severity and duration of chemotherapy-induced stomatitis in children undergoing bone marrow transplantation.


Assuntos
Anti-Inflamatórios/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Homeopatia , Minerais/uso terapêutico , Extratos Vegetais/uso terapêutico , Estomatite/tratamento farmacológico , Adolescente , Adulto , Distribuição por Idade , Anti-Inflamatórios/efeitos adversos , Criança , Pré-Escolar , Método Duplo-Cego , Tolerância a Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Estomatite/induzido quimicamente , Resultado do Tratamento
9.
Isr Med Assoc J ; 3(7): 504-7, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11791417

RESUMO

BACKGROUND: Prevention of cigarette smoking is an important issue in public health policy. Since most adult smokers began smoking in childhood, understanding behavorial factors associated with smoking initiation would contribute to smoking initiation programs. Health-related behavior may vary between different ethnic groups. OBJECTIVES: To determine the prevalence of smoking among Jewish and Arab adolescents in Jerusalem, and whether there are differences in smoking initiation between the two ethnic groups. METHODS: We carried out a cross-sectional survey of all students in the 6th to 11th grades (age range 11-17 years) of a Jewish school and an Arab school in the Jerusalem area, using an anonymous self-completion questionnaire. A total of 791 questionnaires was analyzed, 479 from the Jewish students and 312 from the Arab students. RESULTS: The lowest prevalence of smoking was found among Arab female students and the highest among Jewish female students (9% vs. 41%, P < 0.001). The prevalence of smoking among Jewish and Arab males was similar. More Arab female students smoked than their mothers. Peer pressure seemed to be a more important factor among Jewish students. CONCLUSIONS: This study demonstrated the presence of ethnic differences in smoking prevalence and the reasons for smoking among adolescents in Israel. These results suggest the need for specific smoking prevention policies for different ethnic groups.


Assuntos
Árabes/estatística & dados numéricos , Judeus/estatística & dados numéricos , Fumar/etnologia , Adolescente , Comportamento do Adolescente/etnologia , Comportamento do Adolescente/psicologia , Distribuição por Idade , Árabes/psicologia , Criança , Estudos Transversais , Feminino , Comportamentos Relacionados com a Saúde/etnologia , Inquéritos Epidemiológicos , Humanos , Israel/epidemiologia , Judeus/psicologia , Masculino , Distribuição por Sexo , Fumar/psicologia , Abandono do Hábito de Fumar/etnologia , Abandono do Hábito de Fumar/psicologia
10.
Pediátrika (Madr.) ; 20(10): 355-365, nov. 2000. tab
Artigo em En | IBECS | ID: ibc-13171
11.
Acta Paediatr ; 89(5): 519-22, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10852184

RESUMO

OBJECTIVES: We previously noted that white blood cells (WBC) have increased adhesive properties during bacterial infections. Here, we aim to explore the possibility of using the different adhesive properties of WBC as a means of differentiating between viral and bacterial infections, a common problem in paediatrics. METHODS: The adhesive properties of WBC in the peripheral blood of 25 children with documented bacterial infections, 15 with documented viral infections and 36 with probable viral infections, were studied by means of a leukocyte adhesiveness/aggregation slide test (LAAT). The results of the LAAT were compared with those of the other acute phase reactants, namely WBC, differential count and erythrocyte sedimentation rate (ESR), which were taken in the same blood sample in each patient. RESULTS: The sensitivity, specificity and positive predictive value were 92%, 96%, and 92%, respectively for the LAAT; 83%, 87% and 80% for the ESR; 56%, 78% and 56% for the white blood cell count; and 54%, 74% and 50% for the differential count. CONCLUSIONS: The presence of bacterial infections in children can be tested using a simple slide test to reveal the increased state of leukocyte adhesiveness/aggregation in the peripheral blood. The LAAT is a reliable, rapid and inexpensive test, and it can be a useful laboratory tool for the paediatrician treating a child with acute febrile illness.


Assuntos
Infecções Bacterianas/sangue , Infecções Bacterianas/diagnóstico , Inibição de Migração Celular , Teste de Inibição de Aderência Leucocítica , Leucócitos/citologia , Viremia/sangue , Viremia/diagnóstico , Moléculas de Adesão Celular , Agregação Celular , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Contagem de Leucócitos , Masculino , Sensibilidade e Especificidade
14.
J Pediatr Gastroenterol Nutr ; 29(1): 69-74, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10400107

RESUMO

BACKGROUND: Intestinal ischemia-reperfusion (IR) injury results in cell destruction, which may be mediated by the generation of reactive oxygen species, potentially toxic metabolites of xanthine oxidase. Pentoxifylline (PTX) possesses a variety of biochemical and antioxidant properties that can improve capillary flow and tissue oxygenation. Because of these combined effects, it has been hypothesized that pentoxifylline would protect against intestinal IR. METHODS: Young adult rats were randomly assigned to one of four experimental groups: IR/Placebo (n = 12) in which superior and inferior mesenteric arteries were clamped for 45 minutes and then reopened; IR/PTX (n = 11) in which IR was induced as in the Placebo group, but with 25 mg/kg PTX at 0, 30, and 60 minutes; No IR/Placebo (n = 12); and No IR/PTX (n = 6) in which placebo and PTX were applied with no IR. Blood and intestinal samples were taken for serial thiobarbituric acid-reducing substances (TBARS; index of lipid peroxidation), for xanthine oxidase-xanthine dehydrogenase ratios, glutathione, myeloperoxidase, and histopathology. RESULTS: Animals in the IR/PTX group had lower TBARS and the least severe histopathologic injury. Xanthine oxidasexanthine dehydrogenase ratios were elevated only in IR/ Placebo (0.67+/-0.22 vs. 0.45+/-0.14 in IR/PTX; 0.42+/-0.22 in No IR/Placebo; and 0.40+/-0.11 in No IR/PTX; p = 0.0009). Reduced glutathione was diminished in IR/PTX animals (38.9 +/-1.35 vs. 46.1+/-7.0 in IR/Placebo; 41.1+/-2.5 in No IR/ Placebo; 43.6+/-1.0 in No IR/PTX; p = 0.048). No differences were recorded in myeloperoxidase levels among groups. CONCLUSIONS: Pentoxifylline ameliorates histopathologic signs of injury and decreases lipid peroxidation (TBARS). Normal xanthine oxidase-xanthine dehydrogenase ratios in the treated compared with IR-only animals imply that the protective effect of PTX is at least partially mediated through inhibition of xanthine oxidase.


Assuntos
Sequestradores de Radicais Livres/farmacologia , Intestinos/irrigação sanguínea , Pentoxifilina/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Xantina Oxidase/antagonistas & inibidores , Animais , Estudos de Avaliação como Assunto , Intestinos/patologia , Peroxidação de Lipídeos , Distribuição Aleatória , Ratos , Traumatismo por Reperfusão/patologia , Traumatismo por Reperfusão/fisiopatologia
15.
Chest ; 115(5): 1254-8, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10334136

RESUMO

STUDY OBJECTIVES: The incidence and prevalence of pertussis in adults have increased in recent years. It has been shown that previously immunized adults and adolescents are the main sources of transmission of Bordetella pertussis. The aim of this study was to describe the clinical presentation and the clinical course of pertussis in children and young adults who were immunized previously against B pertussis. DESIGN: Retrospective study. SUBJECTS: Children and young adults who were reported by local physicians to the Department of Epidemiology in the Israeli Ministry of Health with serologically confirmed pertussis and who were immunized previously were included. Information sought included personal data, epidemiologic data, signs and symptoms, laboratory results, initial diagnosis, and treatment. RESULTS: In the 95 previously immunized patients with serologically confirmed pertussis (mean age [+/- SD], 8.9 +/- 4.4 years old; range, 5 to 30 years old), the mean duration from onset of symptoms until the final diagnosis of pertussis was 23 +/- 15 days. The disease was usually atypical and generally mild. All the described patients had cough, usually prolonged, lasting 4 +/- 3.6 weeks. Only 6% had the classic whoop. The mean WBC count was 8.7 +/- 2.6 cells/mm6, and the lymphocyte count was 40 +/- 12%. Two patients were admitted to the hospital for severe pneumonia. Among the reported cases, the proportion of patients between the ages of 10 and 45 years increased from 6.5% during the period from 1971 to 1980, to 26% during the period from 1980 to 1990, and to 38% during a 1989 outbreak. CONCLUSIONS: Pertussis in previously immunized individuals is usually characterized by an atypical and relatively mild clinical course. Patients suffer mainly from a prolonged and persistent cough. Early diagnosis may lead to prompt administration of therapy. Prophylaxis of exposed persons might be effective in decreasing both severity and transmission of the disease.


Assuntos
Imunização , Coqueluche/diagnóstico , Adolescente , Adulto , Criança , Pré-Escolar , Humanos , Contagem de Leucócitos , Estudos Retrospectivos , Coqueluche/sangue , Coqueluche/imunologia , Coqueluche/prevenção & controle
16.
J Pediatr Gastroenterol Nutr ; 28(2): 182-5, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9932852

RESUMO

BACKGROUND: Right lower quadrant abdominal pain may pose a diagnostic problem in patients with cystic fibrosis. Abdominal ultrasound examination, used commonly in the diagnostic work-up, may reveal abnormalities of the appendix. However, interpretation of such findings is problematic, because the appearance of the gastrointestinal system during routine examination has not been documented in patients with cystic fibrosis. The purpose of this study was to investigate the findings during routine abdominal ultrasound scans in our cohort of patients with cystic fibrosis and in control subjects. METHODS: Abdominal ultrasound scans were performed prospectively during routine clinic visits in a cohort of patients with cystic fibrosis. RESULTS: Fifty patients aged 10+/-6 years, (range, 0.5-28 years) were examined; 45 had pancreatic insufficiency. Four patients (3 with pancreatic insufficiency) reported right lower quadrant pain at the time of the scan. According to standard ultrasound criteria, the appearance of the appendix was abnormal in 8 patients (16%), 6 had a mucoid appendix, and 2 had a pathologically thickened appendiceal wall. Only 1 of these 8 patients mentioned abdominal pain at the time of the study. Other incidental findings included gallstones (3 patients), intussusception (2 patients), and pancreatic cyst (1 patient). CONCLUSIONS: Abnormalities can be observed during routine abdominal ultrasonographic studies in cystic fibrosis. These findings may not be associated with abdominal pain; their clinical relevance needs further investigation.


Assuntos
Abdome/diagnóstico por imagem , Fibrose Cística/diagnóstico por imagem , Dor Abdominal , Adolescente , Adulto , Apêndice/diagnóstico por imagem , Doenças do Ceco/complicações , Doenças do Ceco/diagnóstico por imagem , Criança , Pré-Escolar , Estudos de Coortes , Fibrose Cística/complicações , Insuficiência Pancreática Exócrina/complicações , Insuficiência Pancreática Exócrina/diagnóstico por imagem , Feminino , Humanos , Lactente , Masculino , Estudos Prospectivos , Ultrassonografia
17.
Pediatrics ; 103(1): 52-7, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9917439

RESUMO

OBJECTIVE: The aim of this study was to define the role of possible risk factors for the development of cystic fibrosis (CF)-related liver disease and to analyze the association between liver disease and the different genotypes present in the Israeli CF patient population. PATIENTS AND METHODS: All patients followed at the seven CF centers in Israel were included in this study. Liver disease was determined by persistently elevated serum liver enzymes and/or bilirubin, and/or significant ultrasonographic changes suggestive of chronic liver disease. The following clinical parameters were evaluated: ethnic origin, age at assessment of liver function, sex, history of meconium ileus, pancreatic function, history of distal intestinal obstruction syndrome, pulmonary function, and cystic fibrosis transmembrane conductance regulator mutation analysis. RESULTS: Of the 288 patients screened, 80 (28%) had liver disease. Of the 256 patients with pancreatic insufficiency, 80 (31%) had liver disease compared with none of the 32 patients with pancreatic sufficiency. Genotype-phenotype correlation was performed on 207 patients carrying identified mutations that were previously classified according to phenotype severity. Liver disease was found in 56 (32%) of 173 patients carrying mutations associated with a severe phenotype and in 6 (38%) of 16 patients carrying at least one mutation associated with a variable genotype (G85E and/or 5T allele). None of the 18 patients carrying the 3849+10kb C->T mutation had liver disease. Prevalence of liver disease increased with age. No correlation was found between liver disease and severity of lung disease, nutritional status, history of meconium ileus, or distal intestinal obstruction syndrome. CONCLUSION: CF patients who have pancreatic insufficiency and carry mutations associated with a severe or a variable genotype are at increased risk to develop liver disease.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/complicações , Hepatopatias/etiologia , Adolescente , Adulto , Árabes , Criança , Pré-Escolar , Fibrose Cística/classificação , Fibrose Cística/etnologia , Fibrose Cística/genética , Insuficiência Pancreática Exócrina/complicações , Feminino , Genótipo , Humanos , Lactente , Israel , Judeus , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Mutação , Fenótipo , Fatores de Risco , Índice de Gravidade de Doença
18.
Eur J Clin Nutr ; 53 Suppl 3: S14-9, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10723642

RESUMO

Scientific and expert advisory committees responsible for food products often have the advantage of being relatively unhindered by rigid regulations and the simultaneous disadvantage of having few guidelines to clarify their role in directing the research and approval process. Committees can thus miss opportunities to function in a proactive advisory capacity, and to assist in predetermining what research and documentation are necessary for regulatory approval of a particular food product. This paper examines the ways scientific and expert committees for nutritional products can contribute to formulation of procedures for effective hypothesis and study design development, preparation of well-structured, complete dossiers for product approval, and transparent interactions with petitioners.


Assuntos
Indústria Alimentícia/normas , Legislação sobre Alimentos , Pesquisa/organização & administração , Ensaios Clínicos como Assunto , Europa (Continente) , Guias como Assunto , Humanos , Pesquisa/normas , Projetos de Pesquisa , Estados Unidos
19.
Pediatr Pulmonol ; 26(3): 162-6, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9773910

RESUMO

Corticosteroids continue to be used by many physicians to treat infants with bronchiolitis. The aim of this study was to examine the short-term and long-term efficacy of oral corticosteroid therapy when added to beta2-agonists in infants with mild to moderate bronchiolitis (defined as the first episode of wheezing associated with low grade fever, rhinitis, tachypnea, and increased respiratory effort in a previously healthy infant during the winter months). Infants with mild to moderate bronchiolitis, were randomly assigned to receive either oral prednisone (2 mg/kg/day) or placebo for 3 days. All patients received nebulized albuterol q.i.d. during this period. Upon admission and after 3 days of therapy, a clinical score was assigned based on respiratory rate, use of accessory muscle, and the presence of wheeze. Oxygen saturation (SaO2) was also measured. On day 7, we inquired as to the well-being of each child. Two years later, the development of chronic respiratory symptoms was assessed. Thirty-eight infants were enrolled in the study; 20 received prednisone and 18 received placebo. Both groups were similar in terms of age, duration of illness prior to enrollment, pretrial medication use, clinical severity of bronchiolitis, history of atopy, and family history of atopy. After 3 and 7 days of treatment, both groups showed similar clinical improvement and there were no statistically significant differences between the two groups in the clinical score or in the SaO2. No major side effects were observed. Two years later, 32% of the infants continued to suffer from chronic respiratory symptoms, with a similar prevalence in both groups. We conclude that a 3-day course of oral corticosteroids is of no benefit to infants with mild to moderate bronchiolitis who are also treated with an inhaled beta2-agonist.


Assuntos
Bronquiolite/tratamento farmacológico , Glucocorticoides/uso terapêutico , Doença Aguda , Agonistas Adrenérgicos beta/uso terapêutico , Albuterol/uso terapêutico , Método Duplo-Cego , Quimioterapia Combinada , Seguimentos , Humanos , Lactente , Recém-Nascido , Estudos Prospectivos , Resultado do Tratamento
20.
J Pediatr Gastroenterol Nutr ; 27(4): 393-6, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9779965

RESUMO

BACKGROUND: Programmed cell death refers to the genetically determined processes by which cells die in response to physiologic extracellular and intracellular signals, morphologically described as apoptosis. In physiologic and pathologic circumstances this process may involve effector and target cells. METHODS: To identify serine esterase granules in intraepithelial lymphocytes, fresh-frozen human small intestine mucosal sections from normal and celiac-affected mucosa were incubated with substrate-specific N-alpha-benzyloxy-carbonyl-L-lysine thiobenzyl (BLT) and a chromogen (4 Benzoylamino-2,5-diethoxybenzene-dazonium chloride hemi [zinc chloride] salt as capture agent and were examined by light microscopy. RESULTS: Normal mucosa showed an occasional intraepithelial lymphocyte with BLT-positive intracytoplasmic granules. Some large mononuclear cells of the lamina propria were similarly stained. Many more intraepithelial lymphocytes were BLT-positive among the surface enterocytes of untreated celiac mucosa. Lamina propria mononuclear cells close to the basal layer of crypt cells also appeared to be increased. CONCLUSIONS: The histochemical identification of BLT-positive esters within intraepithelial lymphocytes suggests their involvement in enterocyte death under physiologic conditions. The increased BLT-positive intraepithelial lymphocytes found in the celiac mucosa may be related to the known increase in cytotoxic intraepithelial lymphocytes in untreated celiac disease.


Assuntos
Apoptose , Doença Celíaca/patologia , Grânulos Citoplasmáticos/química , Mucosa Intestinal/patologia , Linfócitos/ultraestrutura , Glicoproteínas de Membrana/análise , Criança , Granzimas , Histocitoquímica , Humanos , Linfócitos/fisiologia , Lisina/análogos & derivados , Lisina/análise , Perforina , Proteínas Citotóxicas Formadoras de Poros , Serina Endopeptidases/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...